| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Versant V Luxco S.A R.L. is a 10% Owner at Aprea Therapeutics, Inc.. Recent SEC Form 4 filings include 1 buy and 0 sells.
Estimated insider holdings value: $87K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 7, 2019 | APRE Aprea Therapeutics, Inc. | 10% Owner | Buy | 333,333 | $15.00 | $4,999,995.00 | New |